ACE and COVID-19: Once the virus is attached, the activity of ACE2 is suppressed, which further enhances the activity of ACE1, that accordingly increases the formation of angiotensin II, leading to intensified pulmonary vasoconstriction and severe COVID‐19 reactions (Malek Mahdavi, 2020).